Picard Medical is trading 6.46% lower at $14.34 in pre-market, with no clear company-specific catalyst identified.
- Supplied price context shows a sharp reversal after shares closed at $15.33 on October 13, following two strong sessions.
- A securities-lawsuit update reported October 13 says the company sought dismissal of claims over alleged IPO disclosures.
- Available coverage does not link that update to the pre-market decline.